The effects of sodium valproate on the renal function of children with epilepsy

Area of Science:

• Pediatric Nephrology
• Clinical Pharmacology
• Epileptology

Background:

• Sodium valproate is a common antiepileptic drug.
• Growing evidence suggests valproate can induce renal tubular injury in children.
• Valproate-induced Fanconi's syndrome involves impaired renal tubule reabsorption.

Purpose of the Study:

• To review studies on valproate's renal effects in epileptic children.
• To analyze data on subclinical and clinical valproate-induced nephrotoxicity.
• To identify children who may benefit from renal function monitoring.

Main Methods:

• Literature review of studies on valproate and pediatric renal function.
• Categorization of research into subclinical (enzyme markers) and clinical (Fanconi's syndrome) findings.
• Analysis of patterns in reported cases of renal injury.

Main Results:

• Studies indicate subclinical tubular injury measured by renal enzymes (e.g., N-acetyl-β-D-glucosaminidase [NAG]).
• Clinical reports document cases of valproate-induced Fanconi's syndrome.
• Recurring patterns suggest a susceptible subpopulation of children.

Conclusions:

• Severely disabled epileptic children on valproate may be at higher risk for renal injury.
• Close monitoring of renal enzymes (especially NAG) or urinalysis is advised for this population.
• Proactive monitoring can help detect and manage valproate-induced nephrotoxicity early.